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A B S T R A C T   
In the late 70’s, the discovery of the restriction enzymes made possible the biological production of functional 
proteins by recombinant DNA technologies, a fact that largely empowered both biotechnological and pharma-
ceutical industries. Short peptides or small protein domains, with specific molecular affinities, were developed as 
purification tags in downstream processes to separate the target protein from the culture media or cell debris, 
upon breaking the producing cells. Among these tags, and by exploiting the interactivity of the imidazole ring of 
histidine residues, the hexahistidine peptide (H6) became a gold standard. Although initially used almost 
exclusively in protein production, H6 and related His-rich peptides are progressively proving a broad applica-
bility in novel utilities including enzymatic processes, advanced drug delivery systems and diagnosis, through a 
so far unsuspected adaptation of their binding capabilities. In this context, the coordination of histidine residues 
and metals confers intriguing functionalities to His-rich sequences useable in the forward-thinking design of 
protein-based nano- and micro-materials and devices, through strategies that are comprehensively presented 
here.   
1. Introduction 
Protein purification is an essential practice in biotechnology, drug 
development and proteomics, and a late downstream step in the re-
combinant protein production task flow (Garg et al., 1991; Gräslund 
et al., 2008). Considering the diversity of cell factories and target pro-
teins in the protein production scenario, simple, one-step separation 
protocols are ideally required to fulfill the demands for generality, 
scalability, and high throughput (Fig. 1A). In this context, affinity tags, 
namely peptides or proteins with selectivity for specific binders have 
been incorporated to recombinant proteins by genetic fusion, usually at 
either the amino or carboxy termini, to selectively retain the whole 
fusion in affinity chromatography systems based on immobilized ligands 
(Amarasinghe and Jin, 2015; Kimple and Sondek, 2004; Mishra, 2020). 
Essentially, any pair of interactors involving at least a peptidic partner 
should be suitable for the design of entrapment protocols to retain a 
specific protein among complex molecular mixtures such as cell lysates 
or culture media. 
Since the 70’s (Porath et al., 1975) and along decades (Gaberc-Por-
ekar and Menart, 2001; Porath, 1992; Riguero et al., 2020; Spries-
tersbach et al., 2015; Sulkowski, 1985), immobilized metal affinity 
chromatography (IMAC) has proved to be a robust choice method for 
preparative protein purification because of its versatility, cost effec-
tiveness, scalability and simplicity, compliant with high-throughput 
requirements. The IMAC concept is supported by the relatively strong 
interactions between transition metal ions (namely Ni2+, Cu2+, Zn2+ and 
Co2+) and the side chains of some particular amino acids. Among them, 
the amino acid histidine is the tightest binder through the electron donor 
group on its imidazole ring, that forms coordination bonds with the 
metal (Watly et al., 2014). If immobilized in a matrix, the metal acts as a 
molecular hook for histidine-rich protein segments, that can be further 
eluted from the matrix by adjusting the buffer pH or by adding excess 
imidazole. Since series of consecutive histidine residues confer a much 
tighter binding than isolate amino acids (Bornhorst and Falke, 2000; 
Gaberc-Porekar and Menart, 2005), polyhistidine stretches and specially 
H6, have become gold standard affinity tags for protein purification 
* Corresponding authors. 
E-mail addresses: antoni.villaverde@uab.cat (A. Villaverde), esther.vazquez@uab.cat (E. Vázquez), uunzueta@santpau.cat (U. Unzueta).   
1 Equally contributed. 
Contents lists available at ScienceDirect 
Biotechnology Advances 
journal homepage: www.elsevier.com/locate/biotechadv 
https://doi.org/10.1016/j.biotechadv.2021.107817 
Received 10 April 2021; Received in revised form 16 July 2021; Accepted 16 August 2021   
Biotechnology Advances xxx (xxxx) xxx
2
(Table 1). In this sense, smaller tags with three to five histidine residues 
can also serve for this purpose (López-Laguna et al., 2019) at the expense 
of a weaker binding. On the other hand, longer histidine tags (e.g. H8 or 
H10) are also an alternative when high purity is needed and optimiza-
tion of H6-tags is not sufficient (Grisshammer and Tucker, 1997). 
Several downsides, however, include the possibility of inhibiting protein 
functions, inducing conformational changes, decreasing the protein 
expression, or requiring higher imidazole concentrations to elute, which 
ultimately lead to unstable proteins in the solution (Mohanty and 
Wiener, 2004). Nevertheless, it is historically assumed that H6 is an 
appropriate choice when designing recombinant proteins unless previ-
ous concerns regarding the desired number of histidine residues exist. 
The binding mediated by histidine residues occurs since at physiological 
pH, the molecular coordinative foci of imidazole rings are found in the 
δ1-Nitrogen atom, which is capable to act as a nucleophilic center and 
share two unpaired electrons with the desired targeting molecule, which 
will act as an electrophilic Lewis acid. In particular, the d-orbitals of 
these electrophiles allow the formation of coordinative bonds whose 
geometrical structures promote the simultaneous gluing of several 
imidazole rings from adjacent His residues (Valenti et al., 2006). This 
type of interaction is strongly held into the structure formed by the 
molecular partners in the complex, supporting mechanical forces that 
sustain the applicability of polyhistidine tails as molecular ligands 
(Lopez-Laguna et al., 2019). 
2. Advanced systems for protein purification 
The traditional IMAC, with divalent cations immobilized on agarose 
resin beads, basically Sepharose, remains as a conventional protocol 
(Loughran et al., 2017). Here, several divalent cations (Co2+, Cu2+, 
Zn2+, Ni2+) are useful for purification purposes and each of them shows 
different binding affinity towards histidine. Its choice therefore, depends 
on the final application. Co2+ for example, forms less stable coordination 
bonds with histidine residues and is especially suitable when high pro-
tein purity is required. On the other hand, Cu2+ has the greatest affinity 
and is useful for enriching low abundant proteins from crude lysates, 
prior to other purification steps. Ni2+ and Zn2+ have an intermediate 
affinity, being nickel the most extended choice (Riguero et al., 2020). In 
all these cases, divalent cations might suffer from leakage from IMAC 
columns and elute with the protein of interest. For some particular ap-
plications, the presence of metal ions may affect protein activity or 
promote undesired reactions. Therefore, in these cases, we must ensure 
that the final product is free of divalent cations. In this sense, some 
commercial protein purification companies have already developed 
resins that show tighter bonds with the divalent cation and propose 
strategies to diminish its presence in the eluted fractions (e.g. using 
prepacked columns, pre-washing the column with elution buffer prior to 
protein purification or connecting an uncharged column just after the 
purification column,in series, to catch leaked ions). An alternative so-
lution is to eliminate eluted ions during the protein dialysis step using a 
chelator such as EDTA, although this chemical compound can also be a 
contaminant for the protein of interest and it must be subsequently 
removed (Mónico et al., 2017). 
Advanced strategies based on this principle have been developed to 
purify His-tagged proteins in a more efficient, sustainable, easier or 
cheaper manner. In this regard, magnetic nanoparticles have emerged as 
a simple, fast, and high-throughput system to purify proteins from 
complex bacterial or animal cell lysates by magnetic separation when 
functionalized with linker-chelating metal ions (Xu et al., 2004), nickel 
silicate (Wang et al., 2014a) or simply a nickel coating (Minkner et al., 
2020). In 2019, Schwaminger and collaborators went a step further with 
a proof of principle of a magnetic one-step purification system, using 
non-functionalized bare iron oxide nanoparticles (BIONs) (Schwaminger 
et al., 2019). Besides IMAC, liquid-liquid extraction with affinity ionic 
liquids has been also used for the same purpose, resulting in a suitable 
method for large-scale purification (Ren et al., 2015). His-tagging has 
served for the purification of structures more complex than single 
polypeptides, such as bacterial outer membrane vesicles (OMVs) (Alves 
et al., 2017), virus-like particles (Gupta et al., 2020) or bacteriophages 
(Ceglarek et al., 2013). 
An additional step in the enhancement of IMAC purification exploits 
nitrilotriacetic (NTA)-Ni2+-His tag coordination complexes (Fig. 1B). 
NTA is an aminopolycarboxylic acid with a tripodal tetradentate nature, 
able to form coordinative interactions with divalent metal ions in a 
bonding type called chelation. The NTA-metal ion complexes can spe-
cifically interact with certain chemically compatible amino acid resi-
dues. Among all different options, imidazole rings from histidine 
residues are extremely good targets, as they offer two non-bonded va-
lences on their surface that are available for further metal ion coordi-
nation. In a general manner, more-than-two NTA (bis or tris) structures 
are needed to ensure a sufficient strong binding between ion and histi-
dine (Fig. 1B). As a result, ternary bis or tris NTA-metal ion-histidine 
stable complexes are formed. From here, the chemical versatility of NTA 
allows this technology to be used in a plethora of different protein en-
gineering fields (Wijeratne et al., 2016). 
Although poorly studied in general terms, His-rich tags are suspected 
to have potential undesired impacts on the structure, function and 
immunogenicity of some of the target proteins (Khan et al., 2012; Singh 
et al., 2020). Such side-effects of His-tagging, mild and case-dependent, 
can be solved by the proteolytic removal of the peptide upon purifica-
tion, driven by a protease target site introduced during the genetic 
fusion (Goh et al., 2017) or by regulatable, Ni2+-mediated hydrolysis 
(Abd Elhameed et al., 2019). More details about the potential bottle-
necks generated by His-tagging are discussed below. Because of these 
issues, alternative affinity tags have been extensively used, such as small 
peptides (FLAG, c-Myc, Strep-Tag) or longer polypeptidic ligands such 
Fig. 1. A. Schematic process to obtain a pure re-
combinant polypeptide (e.g. His-tagged Human 
Serum Albumin, PDB: 1AO6) by means of a His-tag 
genetically fused to the target protein. The sequence 
of activities involves gene design (in which the 
desired protein-encoding gene is fused to the selected 
tag), cloning, transformation in a capable cell factory, 
production in an adequate scale (lab, pilot or indus-
trial), His-tag based immobilization in an IMAC col-
umn (I) and subsequent displacement using imidazole 
(II). B. Zoomed representation of the coordination 
bonding between Ni-NTA and the histidine imidazole 
ring.   
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Table 1 
A summary of applications of His-rich tags in protein sciences.  
Application 
category 





Immobilized Metal Ion Affinity 
Chromatography (IMAC) 
Sepharose beads with immobilized divalent 
metal ions 
Loughran et al. (2017) 
Alternative Material- 
based strategies 
Magnetic NPs  - Linker chelated metal ion NPs.  
- Nickel (II) Silicate NPs.  
- Nickel (II) Coated NPs.  
- Iron oxide NPs (BIONs). 
Minkner et al. (2020); Schwaminger et al. 




Affinity ionic liquid (AIL) Liquid-liquid extraction with affinity ionic 
liquids 





Western Blot Anti His-tag Abs emitting detectable signals Hirano (2012); Kreisig et al. (2014) 
His-tag radiolabeling 99mTc(CO)3-His-tag Technetium-99 attached to His-tags, emitting 
radioactive signals 
Garousi et al. (2020) 
scFv-Bioimaging Histidine tagged monoclonal 
scFv 
scFv Abs recognizing biological compounds 
and His-rich tags allowing cell or tissue 
imaging (e.g. by immunofluorescence, 
immunoelectron microscopy, ELISA or 
Western Blot) 
Min and Yamabhai (2020) 




NTA- Ni2+ complexes label His-tagged proteins 
and conjugated compounds (e.g. ATTOX, 
ALEXAX, OG488, FEW646, BODIPY, arylazide, 
QD and gold nanoparticles) emit detectable 
signals 
Banerjee et al. (2016); Chao et al. (2017);  
Kitai et al. (2011); Kollmannsperger et al. 
(2016); Soh (2008); Wang et al. (2014b);  




strategies for biosensing 
Surface-NTA-Ni2+-His tagged 
proteins 
NTA-Ni2+ complexes conjugated to chemically 
adequate surfaces allowing the detection of 
His-tagged proteins, nucleic acids, biomarkers, 
toxins, immunoglobulins or pesticides 
Dai et al. (2018); Kang et al. (2017); Liu 
et al. (2010); Mikula et al. (2018);  
Povedano et al. (2020); Ravikumar et al. 
(2018); Vallina-Garcia et al. (2007); Zhang 
et al. (2014) 
Alternative 
Immobilization 
strategies for biosensing 
Au-coated probes-NTA-Co3+-His- 
tagged proteins 
Au-coated probes conjugated with NTA-Co3+
complexes used to create SPR Optic biosensors 
immobilizing His-tagged antigens 
Horta et al. (2020) 
Chitosan-Zn2+-His-tagged 
proteins in a quartz crystal 
microbalance (QCM) 
Chitosan-Zn2+ complex immobilize and allow 
the detection of His tagged mycotoxin in 
hapten biosensors using the QCM technology 
Soleri et al. (2015) 
Biocatalysis in glass 
surfaces 
Fe3+ porosity glass carriers with 
immobilized His-tagged enzymes 
Controlled porosity Fe3+ glass carriers used to 
immobilize His-tagged enzymes to catalyze 
reactions 
Pellis et al. (2017) 
Biocatalysis in self- 
immobilized insoluble 
enzymes 
Zn2+ assisted generation of 
reusable insoluble protein 
microgranules 
Generation of H6-tagged β-galactosidase 
microscale granules with enhanced stability 
Sanchez et al. (2021) 
Biocatalysis in 
bioreactors 
Semicontinuous or continuous 
-flow bioreactors with His-tag 
immobilized enzymes 
His-tagged enzymes immobilized in different 
functioning bioreactors promoting successive 
and multi-step product transformations 
Britton et al. (2017); Plz et al. (2020) 
Microfluidic bioreactors with 
magnetic beads attaching His- 
tagged enzymes 
Microfluidic packed-bed bioreactors using 
magnetic beads to attach His-tagged enzymes 
to perform desired enzymatic reactions 
Peschke et al. (2019) 
Bioengineering Glass-plate Ni2+ chelated surface 
with immobilized His-tagged 
growth factor 
Glass-plate Ni2+ surfaces used to enhance in 
vitro proliferation of human mesenchymal cells 
by immobilizing FGF 




Site specific conjugation 




Biological compounds or materials such as 
DNA, nanolipoproteins (MPLA-NiNLP), Au- 
polymer NPs or QD can be chemically attached 
to NTA-Ni2+ complexes and be specifically 
coordinated to His-rich tags from proteins 
Goodman et al. (2009); Rai et al. (2016);  
Shimada et al. (2008); Wilkins et al. 
(2019); Zheng et al. (2016) 
Site specific conjugation 
by alkynyl group 
addition 
Baylis-Hillman ester - ternary 
NTA-Ni2+
Ternary NTA-Ni2+ complexes can be used to 
bring an alkynyl group-carrying ester moiety 
near the imidazole ring of a desired histidines 
for its two stage derivatization with molecules. 
Liu and Melman, 2013) 
Site specific conjugation 
by histidines bis- 
alkylation 
Cation free Sulfone – His bis- 
alkylation. 
Sulfone-mediated bis-alkylation of PEG-bis- 
sulfone or PEG10-mono-sulfone molecules to 
His-tag in desired proteins (e.g. interferon α-2a 
or anti-TNFα domain Ab) 
Cong et al. (2012); Peciak et al. (2019) 
Site specific conjugation 
by cyclic ketone 
generation 
Michael addition of 2-cyclohexa-
none in His residue. 
Orthogonal late-stage installation of aminooxy 
functionalized NMR tags or dyes in exposed 
His residues on protein surface (e.g. lysozyme 
C) 
Joshi and Rai (2019) 
Site specific conjugation 
by histidine acylation. 
D-gluconic acid δ-lactone (GDL) 
and 4-methoxyphenil esters for 
specific acylation of amino- 
terminal His-tags (GHHHn). 
Site specific acylation allows the direct 
addition of a biotin or an azide functional 
group for its subsequent reaction with DBCO- 
functionalized molecules into His-rich tags of 
different proteins (e.g. GFP, MBP or SUMO). 
Martos-Maldonado et al. (2018) 
Protein 
assembling 
Ion-based protein gluing 
to manufacture soluble 
nanostructures 
His-tag/divalent cation/His-tag Divalent cations used as coordinative agents of 
His-tags (interacting with the δ1 nitrogen of 
the histidine imidazole ring) and promoting 
Bai et al. (2013); Brodin et al. (2015);  
Cespedes et al. (2018); Dexter et al. (2006); 
Diaz et al. (2018); Haglin et al. (2017);  
(continued on next page) 
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as Maltose Binding Protein (MBP) or Glutathione S-Transferase (GST) 
(Pina et al., 2014). Also, several novel tags are already under develop-
ment (Spy Tag, Strach Binding Protein, Fluropatite, Diatomite, Beta- 
GRP) trying to reduce protein contaminants and/or production costs 
(Khairil Anuar et al., 2019; Wood, 2014). Related to that, a specific 
solution to increase His-tagged protein purity is the use of low back-
ground cell factory strains, such as Escherichia coli LOBSTR, which is 
engineered to eliminate major His-rich contaminants (Andersen et al., 
2013). 
3. Protein labelling and detection 
3.1. Protein immunodetection 
Specific protein recognition appears as a prior method in proteomic 
profiling, and monoclonal or polyclonal antibody (Ab)-protein immu-
nodetection has raised as one of the most popular methodologies for 
protein identification (Signore et al., 2017). Upon Western Blot, protein 
detection ensures adequate polypeptide identification and quantifica-
tion even in complex samples (Obermaier et al., 2015). Considering the 
large number of H6-tagged recombinant proteins (Loughran et al., 
2017), the importance of using anti-polyhistidine tag antibodies has 
emerged in parallel (Kreisig et al., 2014). In anti-H6-based detection 
techniques (Table 1), a primary monoclonal Ab recognizes the H6 tail, 
followed by a secondary Ab that recognizes the first attached Ab 
(Fig. 2A). Primary (or secondary, binding to primary) Abs are typically 
labelled with organic fluorophores (e.g. Alexa Fluor) or enzymes (e.g. 
alkaline phosphatase and peroxidase) that emit a measurable signal 
(Hirano, 2012) allowing its quantitative detection. 
3.2. Tracking oriented protein labelling 
Interestingly, the popularity of using NTA-Ni2+-His tag coordination 
complexes in protein purification has uplifted in novel protein engi-
neering fields (Johnson and Martin, 2005) and single molecule imaging, 
along with recent H6 radiolabeling (e.g. 99mTc(CO)3) (Garousi et al., 
2020) and single-chain variable fragments (scFv) of monoclonal Abs 
bioimaging (Min and Yamabhai, 2020). Novel formulations of NTA- 
based complexes are being designed to ensure precise protein detec-
tion at sub-nanomolar concentrations and to create clear pictures of 
protein spatiotemporal behavior under physiological conditions (Koll-
mannsperger et al., 2016). The specific conjugation of chromophores (e. 
g. ATTO565, ATTO655, ALEXA647, ALEXA488, OG488, and FEW646 (Koll-
mannsperger et al., 2016; Soh, 2008)), small molecules (e.g. distylryl 
BODIPY or arylazide crosslinkers (Chao et al., 2017)) and other nano-
scale materials (e.g. quantum dots, QD (Banerjee et al., 2016) or gold 
nanoparticles (Kitai et al., 2011)) to these complexes allows exploring 
biological fundamental processes such as viral infections, protein dy-
namics and mobility (e.g. QD-NTA-Ni2+ labelling respiratory syncytial 
virus (Zheng et al., 2016), or Au NPs NTA-Ni2+ labelling dynactin sub-
unit p62 (Kitai et al., 2011)), protein function (e.g. labelling the DNA 
repair protein XPA122 (Chao et al., 2017)), subcellular location (e.g. 
tracing extracellular and intracellular histidine-tagged proteins (Wang 
et al., 2014b), protein targeting, biodistribution and general protein 
pharmacokinetics (Garousi et al., 2020). The tripodal tetradentate na-
ture of NTA allows the eventual interaction with exposed H6 tails 
(Raghunath and Dyer, 2019). Besides the binding affinity of mono-NTA 
is sufficient for IMAC needs (KD: 10 × 10-6 M), the molecular labelling of 
polyhistidine-tagged proteins requires tighter associations to form stable 
complexes useful in biological conditions. Because of that, three NTAs 
are usually associated, named Tris-NTA, to provide sufficient binding 
affinity (KD: 20 × 10− 9 M (Huang et al., 2006)) and to increase the 
complex stability up to 4 orders of magnitude, thanks to the multi-
valency of the system. Tris-NTA-Ni2+ coordinated complexes are being 
used by the scientific community to interact with inner-cell histidine 
tagged proteins without affecting endogenous processes, presenting 
high specificity and low cell toxicity (Kollmannsperger et al., 2016). 
These complexes can be bound to H6-tagged cell penetrating peptides 
(CPPs) to promote cell entrance, and afterwards, spontaneously change 
its preference to bind H10-tagged proteins of interest inside the cell, due 
to the 10-fold higher binding affinity of the longer tag (Schneider and 
Hackenberger, 2017). Also, NTA-Ni2+-red fluorescent probes or similar 
(e.g. AB or BODIPY) complexes can enter into bacteria cells to selec-
tively label histidine-tagged proteins by using appropriate amounts of 
detergents (e.g. Tween 80 (Chao et al., 2017)). The traditional proteo-
mic profiling techniques, together with protein radio-labelling methods 
and NTA-Ni2+-based complexes (Fig. 2B), outpoint the huge versatility 
and applicability of using H6 (or related tags) as labelling target for 
protein characterization and in situ functional imaging. 
4. Protein immobilization in biosensing, biocatalysis and 
bioengineering 
Protein immobilization onto solid surfaces has several applications 
in protein-based biocatalysis, biosensing and bioengineering (Table 1). 
In this sense, among the growing variety of developed protein immo-
bilization methods, including entrapment, adsorption, cross-linking or 
covalent binding, affinity techniques provide a highly specific, 
controllable, and reversible way to anchor proteins to surfaces without 
losing their functional structure (Ley et al., 2011; Zhang et al., 2014). 
Additional benefits of this approach are protein stabilization, protection 
against environmental stresses and reusability in successive processes 
(Rodrigues et al., 2013). Taking advantage of their affinity towards 
divalent metal cations, surfaces or nanomaterials can be decorated with 
His-tagged proteins, rendering uniformly oriented protein layers with 
controlled spatial distribution and without multipoint attachments that 
could impair their functionality (Ley et al., 2011). This chemistry works 
well under mild conditions, at physiological pH and in presence of salts, 
Table 1 (continued ) 
Application 
category 
Strategy Used material or technical basis Approaches Representative references 
adequate nanostructuring (10-350 nm, e.g. 
dimers, coiled coils, nanodiscs, nanocapsules, 
nanorings, helical nanotubes, nanowires, 
interfacial films or tumor targeted NPs) in a 
reversible way (upon addition of EDTA) 
Maniaci et al. (2019); Serna et al. (2020a);  
Serna et al. (2020c); Tunn et al. (2018);  
Unzueta et al. (2020); van Eldijk et al. 
(2016); Zhang et al. (2012) 




His-tag/divalent cation/His-tag Divalent cations used as precipitator agents to 
create functional secretory-like granules at the 
microscale in a reversible way (upon addition 
of EDTA) 
Chen et al. (2019); Jiang et al. (2011);  
Sanchez et al. (2020); Serna et al. (2020b) 
Ab: Antibody; scFv: Single-chain variable fragments; Ni2+: Nickel (II); NTA: Nitrilotriacetic acid; ATTOX & ALEXAX: ATTO565 or ATTO655 and ALEXA647 or ALEXA488; 
QD: Quantum Dots; SPR: Surface plasmon resonance; Au: Gold; Co3+: Cobalt (III); FGF: Fibroblast growth factor; DTPC: DNA-template protein conjugation strategy; 
PEG: Polyethylene Glycol; NMR: Nuclear magnetic resonance; GFP: Green fluorescent protein; MBP: Maltose-binding protein; SUMO: Small ubiquitin-like modifier 
protein; EDTA: Ethylenediaminetetraacetic acid; DBCO: Dibenzocyclooctyne. 
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making it appropriate for applications in biological interfaces (Wegner 
et al., 2016). The conventional procedure to immobilize His-tagged 
proteins involves an earlier step of surface functionalization with NTA, 
followed by the incorporation of the divalent cation, typically Ni2+ (Liu 
et al., 2010). In such process, a deep consideration of surface pretreat-
ment, metal leaching and unwanted dissociation of the His-rich tag from 
the divalent cation-NTA pair is suited (Ravikumar et al., 2018). In this 
regard, a plethora of procedures are emerging to solve these issues 
whilst maintaining the benefits of His-tagged immobilization. For 
instance, alternative strategies involve the use of multiple NTA groups 
(Lata et al., 2005), longer His-rich tags (Lata et al., 2005), different 
chelators (e.g. chitosan (Ravikumar et al., 2018)), acbztacn (Johnson 
and Martin, 2005), 1-acetato-4-benzyl-triazacyclononane (Wollenberg 
et al., 2014), iminodiacetatic acid (Zhao et al., 2017), NiO (Jia et al., 
2016) and polydopamine (Yang et al., 2015)) or the conversion to 
different metal oxidation states (namely Fe3+ (Pellis et al., 2017) and 
Co3+ (Wegner et al., 2016)). In this last case, the process requires a first- 
step of complexation between histidines and a Co2+ ion, followed by a 
subsequent Co2+ ion oxidation into Co3+, resulting in a tight immobi-
lized complex. 
4.1. Biosensing 
In biosensors, His-tagged proteins have been broadly used in optical 
(Auer et al., 2017; Avsar et al., 2020; Faccio et al., 2016; Horta et al., 
2020; Lata et al., 2005; Ravikumar et al., 2018) and electrochemical 
(Dai et al., 2018; Povedano et al., 2020; Vallina-Garcia et al., 2007; 
Zhang et al., 2014) devices and also in piezoelectric transducers (Baltus 
et al., 2007; Li et al., 2016; Nam et al., 2013; Wegner et al., 2016). 
Optical biosensors, mainly based on Surface Plasmon Resonance (SPR) 
or Biolayer Interferometry (BLI), are extensively employed to detect the 
interaction of an immobilized His-tagged protein with its ligand, due to 
a change in the light properties (Fig. 3A). For example, Horta and co- 
workers have recently developed an optical-fiber-based SPR biosensor 
to detect autoantibodies in autoimmune diseases, by immobilizing His- 
tagged antigens on Co3+-NTA Au-coated probes (Horta et al., 2020). A 
similar approach, involving Co3+-His complexes, has been used for 
immobilizing virus-like particles in a BLI biosensor that detects nor-
ovirus antibodies from human serum samples (Auer et al., 2017). 
Moreover, the chemokine receptor CXCR4 has been successfully 
immobilized for studying its interaction with nanobody-Fc ligands, 
which represents an important progress in the study of G protein- 
coupled receptors involved in a broad range of diseases (Boonen et al., 
2020). Electrochemical biosensors tend to be sensitive, fast, simple, 
cheap, and easy-to-miniaturize devices that detect a change in electrical 
properties in the media (Dai et al., 2018; Ley et al., 2011). Their use is 
specially promising in point-of-care facilities, but their susceptibility to 
electrochemical interferences such as pH or ionic strength changes must 
be faced. His-tagged proteins in electrochemical biosensors have been 
used for the detection of nucleic acids (Dai et al., 2018; Povedano et al., 
2020), biomarkers (Ta et al., 2016), toxins (Vallina-Garcia et al., 2007), 
immunoglobulins (Kang et al., 2017; Mikula et al., 2018) or pesticides 
(Zhang et al., 2014). The quartz crystal microbalance (QCM) is a simple, 
label-free, real-time, and efficient tool for the detection of biomolecular 
Fig. 2. A. Overview of size, common labeling strategies, and popular detection techniques available for the study of His-tagged proteins using antibodies. B. Size 
comparison and structure of the Tris-NTA ligand (I), along with common labeling approaches (radiolabeling with Technetium 99m (II) or Tris-NTA-based labeling 
with gold nanoparticles (III), fluorescent dyes (IV) and quantum dots (V)). C. Schematic representation of direct techniques to study subcellular localization of his- 
tagged proteins in vitro (I), co-localization of different his-tagged proteins in vitro (II), or protein bioaccumulation in in vivo models (III). 
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interactions that is based in the measurement of the frequency decrease 
caused by a mass increase (upon interaction) in the functionalized sur-
face (Nam et al., 2013). Its major drawback is the lack of sensitivity for 
small molecules. In a recent report it has been demonstrated the feasi-
bility of QCM to explore the binding properties of a GPCR to its immo-
bilized partner, which provides the basis for studying other similar 
interactions through this technique (Avsar et al., 2020). Finally, myco-
toxin recognition peptides have been also immobilized over Zn2+
adsorbed chitosan foam via His-rich tag for the development of hapten 
biosensors (Soleri et al., 2015). 
4.2. Biocatalysis 
In biocatalysis, immobilization enhances enzymatic stability and 
facilitates product recovery and enzyme reusability. His-rich tag-based 
immobilization has been used for many different reactions in different 
supports. For example, EnginZyme® has developed Fe3+-chelated glass 
carriers with controlled porosity in which His-tagged enzymes can be 
successfully immobilized and perform their activities (Pellis et al., 
2017). Also, H6-tagged β-galactosidase has been self-immobilized using 
a molar excess of Zn2+ as mechanically stable microscale granules, a 
format that allows reusability and that enhances the operational sta-
bility of the enzyme (Sanchez et al., 2021). On the other hand, there is a 
growing tendency to synchronize purification and immobilization of 
His-tagged enzymes in one-step procedures, avoiding the initial on- 
column step and directly working with complex protein mixtures 
derived from cell lysates (Wang et al., 2017). Britton and collaborators 
developed a continuous-flow bioreactor with a 10-min synchronized 
purification and immobilization strategy (Britton et al., 2017). More-
over, they were able to produce a multi-step bioreactor that allows 
successive transformations by controlling spatial distribution of each 
enzyme throughout the bioreactor surface (Fig. 3B). The same principle 
has been applied in semi-continuous bioreactors (Plz et al., 2020). 
Magnetic nanoparticles have been widely used for such dual purpose for 
both intracellular and extracellular proteins obtaining great enzyme 
reusability indexes after several batches (Yang et al., 2015; Zhao et al., 
2017; Zhou et al., 2017). Peschke and co-workers have exploited the use 
of magnetic beads in a microfluidic packed-bed bioreactor with His- 
tagged loaded ketoreductase (Peschke et al., 2019). The use of minia-
turized reactors may be notably important in the future development of 
Fig. 3. A. Schematic representation of biolayer interferometry (left) and surface plasmon resonance (right) in his-tag based biosensing. B. Schematic disposition of 
immobilized enzymes for a sequential biocatalysis in which the product of the first reaction acts as substrate for the second reaction. Common cations used in 
immobilization are Ni2+, Fe3+, Co2+ or Co3+. C. His-tagged protein coating as a bioengineering strategy to enhance cell growth. D. Schematic representation of how 
histidine residues promote protein assembly and secretory granule-like structures with the addition of divalent cations. E. Representation of the wide range of 
nanoscale protein materials that can be assembled by histidine coordination with metal cations such as coiled coils (I), nanowires (II), nanorings (III), toroids (IV), 
nanocapsules (V) and nanotubes (VI). F. Proton sponge effect; illustration of how the decrease in pH in endosomes in presence of his-tagged proteins results in the 
endosomal disruption and subsequent protein liberation. 
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sustainable production processes. 
4.3. Bioengineering 
His-tagged protein immobilization is also useful for bioengineering 
(Fig. 3C). For example, the Fibroblast Growth Factor (FGF) was immo-
bilized onto the surface of a Ni2+ chelated glass-plate to enhance in vitro 
proliferation of human mesenchymal stem cells (Shakya et al., 2020). 
The successful outcome can be directly attributed to the structural 
integrity of the FGF domain in the fusion protein. As it has been done for 
biosensors, Ni2+ has been replaced by Co3+ to stabilize the bond be-
tween His-rich tag and NTA. Di Russo and co-workers proved that such 
replacement results in the development of a higher and broader range of 
E-cadherin adhesion forces, leading to extended cell spreading and 
colony organization (Di Russo et al., 2019). This principle is highly 
relevant for further development of functionalized surfaces for cell 
culture. 
5. Site-specific conjugation 
The functionalities of proteins or protein nanomaterials can be tuned 
by the conjugation of drugs or different organic molecules. As a repre-
sentative example, in the Antibody Drug Conjugates (ADCs) the thera-
peutic molecule is covalently attached to a protein nanocarrier for its 
targeted delivery. Usually, protein nanomaterials are also linked to 
different organic molecules such as Polyethylene Glycol (PEG) to 
improve their pharmacokinetic properties, stability or immunogenicity. 
In all cases, site-directed conjugation is very convenient, not only 
because it would allow molecular binding in a desired and controlled 
position of the protein, but also since such strategies generate more 
homogeneous products with low batch-to-batch variability and with 
higher stoichiometric control. In this sense, engineering of histidine-rich 
motifs within the protein also plays an important role as site-specific 
conjugation targets. 
5.1. Divalent transition metal ion coordination 
As the most explored approach, many molecules chelated to divalent 
transition metal ions such as Ni2+ or Zn2+ have been attached to 
different nanomaterials (Table 1). This is done by the generation of 
ternary complexes with the unpaired electrons in imidazole rings of 
specific histidine residues as previously described. In this sense, NTA- 
modified DNA molecules have been conjugated to proteins such as 
Green Fluorescent Protein (GFP) (Goodman et al., 2009) or alkaline 
phosphatase (Shimada et al., 2008) using Ni2+ ion coordination as a 
molecular glue. This strategy has been also used to attach different types 
of molecules such as monophospharyl lipid A adjuvants containing 
nanolipoprotein particles (MPLA:NiNLP) to His-tagged foot-and-mouth 
disease virus capsids (Rai et al., 2016), or NTA-modified quantum dots 
to progeny virus capsids (Zheng et al., 2016). Further, NTA-modified 
gold-polymer nanoparticles have been also conjugated to His-tagged 
antifreeze peptides to generate new active nanomaterials (Wilkins 
et al., 2019). 
5.2. Templated addition of alkynyl group or lysine conjugation 
Hexahistidine tags can be also used as templates for a first-step 
temporal cation-coordinated molecular binding and subsequent cova-
lent bonding with a neighboring histidine residue within the protein. In 
this sense, templated alkylation of an imidazole residue in a H6 tag can 
be achieved using Baylis-Hillman esters tethered to NTA in presence of 
divalent cations. Here, Ni2+-coordinated ternary complex is generated 
between NTA and two adjacent histidine residues. This event brings the 
reactive double bond of the Baylis-Hillman ester into the vicinity of 
another free imidazole ring for its covalent binding and subsequent 
breaking of the previous NTA bond. This methodology allows the 
successful derivatization of recombinant proteins with a reactive alkynyl 
group that undergo subsequent cycloaddition of molecules (Liu and 
Melman, 2013). 
As a similar approach, the DNA-template protein conjugation strat-
egy (DTPC) allows the initial direction of an NTA-modified oligonucle-
otide to a His-tagged protein. This serves then as a template for 
complementary N-hydroxysuccinimide (NHS)-bearing molecule conju-
gation to a lysine residue, in the close proximity of the histidine-rich tag 
(Rosen et al., 2014). 
5.3. Bis-alkylation of histidine residues 
A more sophisticated His-rich tag specific conjugation methodology 
relies on the bis-alkylation of two histidine residues located close 
together in the target protein by sulfone-containing molecules, without 
the need of any metal chelator. Following this strategy, molecules such 
as PEG have been successfully attached to different His-tagged proteins 
using PEG-bis-sulfone or PEG10-mono-sulfone molecules. Moreover, this 
type of conjugation was successfully achieved using different types of 
polyhistidine tags containing both continuous (H2, H6, H8) or discon-
tinuous (-HGH or -HGHGHG) histidine residues (Cong et al., 2012; 
Peciak et al., 2019). 
5.4. Generation of cyclic ketone 
The use of an electrophile molecule such as 2-cyclohexanone has also 
allowed cation-free site-selective modification of surface-accessible 
histidine residues on a protein. This Michael addition generates a cy-
clic ketone able to form an oxime by the addition of aminooxy-derivative 
probes. Using this methodology, different types of molecules including 
nuclear magnetic resonance (NMR) tags, fluorescent dyes or biotin have 
been successfully attached to a His-tagged protein (Joshi and Rai, 2019). 
5.5. Histidine acylation 
Finally, in a similar approach, specific acylation of an optimized 
amino-terminal histidine tag (GHHHn) has been also reported using D- 
gluconic acid δ-lactone (GDL) and 4-methoxyphenil esters. This His-rich 
tag specific acylation methodology has allowed the introduction of small 
reactive groups such as azides in different proteins including GFP, 
maltose-binding protein (MBP) or the small ubiquitin-like modifier 
protein (SUMO) for further reaction with DBCO-functionalized mole-
cules or direct conjugation of biotin (Martos-Maldonado et al., 2018). 
6. Refined protein assembling and functional protein 
aggregation 
Artificial but largely bioinspired nanostructured materials have been 
developed based on protein building blocks, with high precision and 
structural complexity, integrating order and dynamics into the system 
(Hamley, 2019; Korpi et al., 2020). Among the different protein-based 
assembling approaches, simple fusion protein engineering permits the 
incorporation of peptidic cross-interactors and the facile synthesis of de 
novo multimeric nanomaterials. This is done by bottom-up fabrication 
approaches that ensure a control over the range of biochemical (e.g. 
specificity, bioactivity or biodegradability) and physical (e.g. small size, 
conformation or multivalency) properties (Mendes et al., 2013). His-rich 
tags in recombinant fusion proteins have been empirically tested to 
construct regular, stable and highly versatile nanocarriers with pseu-
dospherical architectures (Lopez-Laguna et al., 2019), highly suited for 
precision intracellular drug delivery (Falgas et al., 2020; Pallares et al., 
2020). One of the most exploited chemical mechanisms that drives the 
assembling process based on H6 tags is the ion-based gluing (Lopez- 
Laguna et al., 2020). In this regard, divalent cations (e.g. Ni2+, Mg2+, 
Cu2+, Co2+, Zn2+, and Ca2+) are able to simultaneously coordinate 
more-than-one histidine residues from overhanging histidine tails, 
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promoting building block recruitment and adequate protein organiza-
tion at the nanoscale (Fig. 3D). This process, usually renders materials 
ranging between 10 and 350 nm, which are efficiently disassembled by 
EDTA (Lopez-Laguna et al., 2020). The gluing process takes place when 
the respective ion interacts with the nucleophilic electron pair from δ1 
nitrogen of the histidine imidazole ring and accommodates at least 2 
near-in-space building blocks into the final oligomeric structure. These 
interactions could also take place when carboxyl groups from asparagine 
and glutamine amino acid residues are close by (Erthal et al., 2016; 
Lopez-Laguna et al., 2019). When envisaged for biomedical applica-
tions, engineering ionic doses should be appropriately adjusted to avoid 
possible systemic toxicity as stated in the recommended dietary allow-
ance (RDA) (Lopez-Laguna et al., 2020). A huge variety of different H6- 
tagged materials have been lately constructed (Table 1) with different 
morphologies and pointing to different applications (Fig. 3E). 
In this sense metal-controlled protein dimers have been generated 
upon zinc binding to designed histidine residues (Maniaci et al., 2019), 
which in some particular cases such as CheA/W chemoreceptors can 
further assemble into ternary complexes to generate functional arrays 
(Haglin et al., 2017). The bioengineering of strategically placed metal- 
coordinating histidine residues has also allowed the generation of syn-
thetic coiled coil structures (Tunn et al., 2018). Going still further, the 
combination of specifically oriented metal coordinating histidines with 
additional intrinsic non-covalent interactions has allowed the genera-
tion of more sophisticated nanostructures. These include linear nano-
wires of different lengths (Zhang et al., 2012), circular nanorings whose 
diameters can be regulated by tuning the strength of the non-covalent 
interactions (Bai et al., 2013), or even multi-responsive triblock copo-
lypeptides that self-assemble as 20 nm diameter nanocapsules (van 
Eldijk et al., 2016). Other sophisticated structures, generated through 
metal-histidine interaction, also include helical nanotubes, whose 
widths can be controlled by solution conditions (Brodin et al., 2015), 
stimuli-responsive interfacial films (Dexter et al., 2006) or toroid 
nanoparticles (e.g. toxin-based (Diaz et al., 2018; Serna et al., 2020a), 
venom-based (Serna et al., 2020c) GFP-based (Cespedes et al., 2018; 
Pallares et al., 2020; Unzueta et al., 2020) or human nidogen-based 
(Alamo et al., 2021), either being intrinsically toxic or delivering 
coupled antitumoral drugs (e.g. floxuridine or monomethyl auristatin 
E). Finally, in a step further regarding structural complexity, functional 
secretory-like granules at the micro scale have been generated also 
through controlled protein aggregation via H6 tag–divalent cation co-
ordination. These artificial aggregates permit the slow release of a 
protein drug in a prolonged manner, then acting as a sustained drug 
release systems aimed at reducing the need of repeated doses (Chen 
et al., 2019; Jiang et al., 2011; López-Laguna et al., 2021; Sanchez et al., 
2020; Serna et al., 2020b). 
7. Systemic administration for therapeutic applications 
When proteins with histidine tails are meant to be used for 
biomedical purposes, it is essential to know whether histidine tails could 
change the behavior of therapeutic proteins when they are applied in 
vivo. It is especially critical to study whether histidines play a role in 
protein biodistribution as well as subcellular localization. To this pur-
pose, different clarifying studies have been carried out, the results of 
which are described below. 
7.1. Biodistribution 
Because of their universal use as purification tags, the potential 
impact of His-rich tails in the biodistribution of systemically adminis-
tered proteins and their implication in drug delivery have been carefully 
explored in different experimental settings. In these studies, the role of 
the amino acid composition of the histidine-rich tail has been evaluated, 
using intercalated hydrophobic or hydrophilic amino acids with 
different charges and upon an H-X-H-X-H-X arrangement (Hofstrom 
et al., 2013), which still allows an efficient purification through 
immobilized metal affinity chromatography (Knecht et al., 2009). Be-
sides this, the influence of the position of the tag at the carboxy or amino 
terminal end of the protein has been studied (Hofstrom et al., 2013; 
Hofstrom et al., 2011; Tolmachev et al., 2010; Vorobyeva et al., 2019) 
by using radioactive labeling, to determine their organ biodistribution in 
mouse models. The resulting data indicated that variations in the body 
localization of the materials do not rely exclusively on the histidine tail, 
but also on the presence of charges and hydrophobic patches on the 
scaffold protein and the way they are distributed (local vs. overall) on 
the protein surface (Hofstrom et al., 2011; Lindbo et al., 2016; Tol-
machev et al., 2010). Even though the different studies are not compa-
rable due to the use of different chimeric scaffold proteins such as 
affibodies (Altai et al., 2016; Hofstrom et al., 2011; Mitran et al., 2015; 
Tolmachev et al., 2010), nanobodies (Singh et al., 2014), scFvs (Casey 
et al., 1995), toxins (Altai et al., 2016), uniCAR target modules (Jurec-
zek et al., 2019), ADAPT scaffolds (Lindbo et al., 2016), DARPIN scaffold 
(Vorobyeva et al., 2019) and also due to different linker chemistry for 
radioactive tagging (Lindbo et al., 2016), it can be globally inferred that 
hydrophobic domains and positively charged areas favors liver uptake 
(Altai et al., 2016; Hofstrom et al., 2013; Mitran et al., 2015; Singh et al., 
2014; Tolmachev et al., 2010). In this sense, His-based tails like (HE)3, 
hydrophilic and negatively charged, could help to counterbalance the 
hydrophobicity and positive charges of the area (Hofstrom et al., 2013; 
Hofstrom et al., 2011; Mitran et al., 2015; Tolmachev et al., 2010), while 
(HT)5, uncharged, gets mostly cleared by kidneys (López-Laguna et al., 
2019). Also, poly-histidine tails at the amino terminal end show, in 
general, a low level of nonspecific organ uptake, especially in kidney 
(Hofstrom et al., 2013; Hofstrom et al., 2011; Vorobyeva et al., 2019). In 
contrast, other studies show that the histidine tail does not affect 
significantly the biodistribution of the protein (Casey et al., 1995; 
Jureczek et al., 2019; Lindbo et al., 2016), indicating again that changes 
of the protein fate in the body depend more on the overall distribution of 
charged and hydrophobic amino acids of the His-tagged protein than on 
the mere presence and nature of the His-rich tag (López-Laguna et al., 
2020). Of course, all these concepts and considerations have important 
implications in the therapeutic applications of His-tagged proteins. 
7.2. Intracellular trafficking 
His-rich tags have been exploited as endosomal escape enhancers to 
deliver proteins or nucleic acids to the cytosol due to their ability to 
trigger osmotic swelling and endosomal disruption (Ferrer-Miralles 
et al., 2011). Since the pKa of their lateral chain imidazole group is 
around 6.0, histidine residues undergo protonation state change from 
neutral to positive when endosomal lumen becomes acidic. In conse-
quence, not only H+ protons enter the lysosomes, but Cl− anions also do 
it likewise in order to equilibrate charges, which generates an osmotic 
pressure that ends up with membrane disruption, namely the proton 
sponge effect (Fig. 3F). Following this mechanism, His-tagged proteins 
can promote higher cytosolic delivery of their cargo molecule (e.g. 
nucleic acids and other drugs (Ferrer-Miralles et al., 2011)) into the 
cytosol. Also, based on their selective protonation at acidic pH, histi-
dines has resulted attractive in the design of novel endosomolytic pep-
tides (Boeckle et al., 2006; Paray et al., 2021). In this regard, the number 
of histidine residues, their distribution in the primary sequence and the 
endosomal vesicle size and membrane leakiness, has been described to 
affect this process (Ahmad et al., 2019; Kichler et al., 2007; Lo and 
Wang, 2008; López-Laguna et al., 2020; Vermeulen et al., 2018). 
(Munsell et al., 2016; Smith et al., 2019). Therefore, His-rich tag- 
dependent proton sponge effect can be considered a lysosome-specific 
membrane disruption system, although its real impact in promoting 
endosomal burst remains still controversial 
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8. Bottlenecks associated to polyhistidine tags 
Because of the chemical versatility of His-rich tags, a plethora of 
different functional materials and surfaces have been constructed 
following bottom-up rational approaches. In this sense, although no 
intrinsic signs of cytotoxicity has been reported in the literature for 
polyhistidine tags, its potential influence over the protein structure, 
stability or function should be precisely considered when designing 
devices for biotechnological or biomedical applications (Zhao and 
Huang, 2016). Interestingly, while B-factor values (reflecting thermal 
motion) were usually slightly higher in His-tagged proteins, no signifi-
cant structural effects have been generically observed neither in both 
resolution or R-factor (reliability factor) when considering a broad 
spectrum of crystallographic 3D protein structures with or without fused 
His tags (Carson et al., 2007). Similar results were obtained in recom-
binant GFP-based fusion proteins, in which H6 was placed in either the 
amino or carboxy termini or in a permissive solvent-exposed loop of the 
GFP barrel. In all cases, protein fluorescence remained intact and puri-
fication took place without any technical issues (Voltà-Durán et al., 
2019). 
8.1. Conformational impact 
However, the influence of H6 tags on structural propensities and 
internal dynamics of small peptides might be more noticeable. While 
small peptides are highly mobile with no unique preferred spatial 
conformation, the addition of certain peptides such as His-based tags, 
triggers small chemical shifts and changes relaxation properties, being 
translated into long-range effect on overall structural propensities 
(Bräuer et al., 2019). This possibility was demonstrated when studying 
the His-rich tag effects on zinc finger proteins, in which the addition of 
those peptides either at their amino or carboxy-terminal positions pro-
moted changes in their native or complexed-with-zinc CD spectra, 
unfolding profiles under urea degeneration tests, and protein function-
ality (Zhao and Huang, 2016). Alike influences were observed in di-
sulfide bond structures but not in the binding behavior of the rat 
corticotropin-releasing factor receptor 2a in a His-rich tag carrying 
version (Klose et al., 2004). In this regard, while a huge catalogue of 
proteins should not be nearly affected by His-rich tag fusion, enzymes 
appear as a special and particular group sensitive to small structural 
changes by either creating or depleting functional scenarios. In this 
context, the carboxy-terminal tagging of tropinone reductase enzyme 
impaired its enzymatic activity while the amino-terminal tagged version 
remained fully active (Freydank et al., 2008). In agreement with that, in 
silico modelling of the protein structure showed an interference of the 
H6-tag with the enzyme active site by steric and electrostatic in-
teractions only when placed at the carboxy terminal (Freydank et al., 
2008). Similar scenarios were also described in L-lactate dehydrogenase, 
in the molybdoenzyme YedY, in secretory leukocyte protease inhibitors 
(SLPIs) and in hormone-sensitive lipases (HSL), in which the carboxy- 
terminal (Halliwell et al., 2001; Munadziroh et al., 2020; Sabaty et al., 
2013) or the amino terminal (Wang et al., 2019) tagging resulted in 
reduced activities. The H6 tag fusion can also elicit a modulatory in-
fluence on the enzymatic activity of certain proteins and be used 
therefore as an advantage, as observed in the catalytic capacity of the 
nuclease domain of the Colicin E7 metallonuclease (NColE7) from E. 
coli, an enzyme used by E. coli to kill competing bacteria under stress 
conditions (Abd Elhameed et al., 2020). In this regard, the interference 
of the oligohistidine peptide tag with the Zn2+ containing active center 
was used for the regulation and fine tuning of the enzymatic activity. 
From another point of view, scanning fluorimetry profiles displayed 
both beneficial and deleterious effects on the thermal stability of the 
protein, depending on the presence or absence of a H6 in the amino- 
terminus (Booth et al., 2018) possibly due to an occasional architec-
tonic rearrangement of the final protein structure. Mild and case- 
associated modulation of protein solubility have been also 
occasionally observed upon His-rich tag fusion (Woestenenk et al., 
2004). 
The variability of the already presented conformational scenario 
opens up to the idea of using small peptide linkers to reduce the 
conformational impact of fusion his-rich tags and to ensure an adequate 
conformational structure thus refining the design of bioactive fusion 
proteins. In this sense, three major categories of linkers can be found 
according to their physicochemical or functional properties (flexible, 
rigid or in vivo cleavable), which can be selected depending on the 
particular scientific needs. In fact, these linkers could not only 
contribute to minimize the conformational impact of introduced tags 
over the protein but also improve the biological properties of the tagged 
protein by increasing their production yields, by achieving desirable 
pharmacokinetic profiles or by improving their biological activity. In 
this regard, flexible linkers appear as the most appropriate ones to 
reduce the conformational impact of the histidine tag, as they confer 
sufficient mobility and flexibility to such tag. Flexible linkers are 
generally composed by small and either polar (e.g. Serine; Ser or Thre-
onine; Thr) or non-polar (Glycine; Gly) amino acid residues. Their small 
size allows the protein sequence being sufficiently mobile, and their 
polarity contribute to protein stability in aqueous solution not only by 
forming hydrogen bonds with water molecules, but reducing the unfa-
vored interactions between other protein regions. The most commonly 
used flexible linkers include (Gly-Gly-Gly-Gly-Ser)n or (Gly-Ser)n se-
quences. In this sense, the n value could be adjusted for an optimized 
separation between functional domains, or to maintain necessary inter- 
domain interactions. Although Gly and Ser are the most used amino 
acids, Thr and Alanine (Ala) could be also introduced to maintain suf-
ficient structural flexibility and Lysine (Lys) and Glutamine (Glu) to 
improve sequence solubility. In all cases, the rational design should be 
supported by experimental data, ensuring the optimization of the linker 
sequence, in order to fit with the particular needs linked to the recom-
binant protein (Argos, 1990; Chen et al., 2013). 
8.2. Immunogenicity 
On the other hand, immunogenicity assessment is paramount to 
ensure the safe and effective development of therapeutic proteins (Ishii- 
Watabe et al., 2018), since mitigation or full ablation of immunological- 
based adverse events such as anaphylaxis, cytokine release syndrome, 
and cross-reactive neutralization of endogenous proteins is mandatory 
(Lau and Dunn, 2018; Tourdot and Hickling, 2019). Indeed, immuno-
genic responses correspond to the most common non-desired side effects 
of proteins in clinics. In this scenario, protein-based drugs are currently 
transforming the pharmaceutical industry, displaying an unpreceded 
potential specially in precision medicines (Sanchez-Garcia et al., 2016; 
Serna et al., 2018) and promoting the development of highly effective 
treatments (Lagasse et al., 2017). Then, immunogenicity of potential 
tags used in production might be a critical issue (Tourdot and Hickling, 
2019). From here, a dichotomy appears; while a large catalogue of 
manufactured proteins with clinical potential are His-tagged, a public 
concern shows up in which the use of H6 tag is discouraged by the Food 
and Drug Administration (FDA) and the European Medicines Agency 
(EMA) due to its potential non-desired immune response, although no 
official specifications are publicly indicated. In this context, alternative 
histidine-rich tags have been designed and tested with the aim of solving 
these regulatory concerns. For that, humanized versions, alternative to 
the traditional H6, were constructed derived from BLAST-ed human 
proteins namely H3A (HAAHAH), H5T (HTHTHTHTH) and H5E 
(HEHEHEHEH). Interestingly, all humanized His-tag versions main-
tained their protein production, purification and functional properties, 
displaying a huge potential to be used in humanized biomedicines 
(López-Laguna et al., 2020). 
From a technical point of view, part of the scientific community 
considers H6 sequences as safe tags, due to its small size (0.84 kDa), 
absence of electric charge (non-interactive material), and low cell 
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toxicity and immunogenicity (Loughran et al., 2017). This is of course in 
addition to the very convenient potential of His-rich segments as puri-
fication tags, at low costs and under mild imidazole-promoted elution 
and native or denaturing conditions (Lau and Dunn, 2018; Loughran 
et al., 2017), making feasible the industrial production of protein drugs. 
Notably, protein BLASTs also shows coincidences in more-than-six 
consecutive histidine segments found in human proteins, hinting that 
human immune system is not expected to react when administering H6- 
tagged formulations (López-Laguna et al., 2020). Besides this conceptual 
consideration, there is no huge quantity and detailed experimental facts 
describing H6 immunogenicity, neither in vivo nor in vitro. In addition, 
His-rich tags have been included in multiple vaccine candidates against 
malaria (Angov et al., 2003; Dutta et al., 2002; Otsyula et al., 2013), 
proceeding as far as phase IIb in clinical trials without apparent safety 
concerns in vaccinated children (Jin et al., 2017). A similar scenario was 
observed in tandem phase I studies evaluating reactogenicity, safety and 
immunogenicity of His-tagged antigens (Plasmodium falciparum surface 
protein; MSP142) administered intramuscularly with AS01 as adjuvant 
(Otsyula et al., 2013). On the other way around, the amino-terminal His- 
tagged Streptococcus pneumoniae surface protein SP08456 promoted 
undesired immunogenic responses when administered intramuscularly, 
in comparison to its non-tagged version for bacteria immunization in 
Balb/c mice (Singh et al., 2020). In short, there are not experimental 
concluding remarks that support or preclude the use of His-tagged drugs 
into clinics. 
8.3. Catalytic activity of imidazole rings 
The addition of His-tags in recombinant proteins for purification or 
other purposes may not be as innocuous as previously thought. Imid-
azole rings appear to be reactive species able to catalyze specific enzy-
matic reactions, and so changing the resulting properties of the His- 
tagged protein material. 
In this sense, the catalytic function of the imidazole ring has been 
reported since 1956 in several scenarios, in which different types of 
polymers, nanoparticles, peptide bundles and nanofibers have been 
involved (Bai et al., 2011; Chadha and Zhao, 2013; Giusti et al., 2014; 
Guler and Stupp, 2007). Indeed, this chemical group has been described 
as able to catalyze the transformation of p-nitrophenyl acetate hydro-
lysis (p-NPA) (Denmark et al., 1990), as well as, having a capital role in 
aldol-based and RNA cleavage reactions (Anslyn and Breslow, 1989; 
Breslow, 1994; Kirby and Marriott, 1995; Markert et al., 2009; Scheffler 
and Mahrwald, 2012). Its chemical versatility (especially when con-
forming the side chain of the histidine amino acid) lies in its amphoteric 
nature. Thus, the imidazole ring is able to lose a proton via its pros ni-
trogen atom or to accept a proton via its tele nitrogen atom at pHs close 
to 7 (Schneider, 1978). Because of that, histidine residues are suitable 
for both nucleophilic and base catalysis reactions, in addition to the 
traditional metal coordination functions. 
Therefore, due to this intrinsic chemical reactivity of the imidazole 
ring, His-tags might be not biologically inert when fused to a protein. 
Among the different experimentally described scenarios, the His-tag can 
present esterase activity as reported in a GFP-H6 protein model, being 
able to convert p-NPA to p-nitrophenol and acetic acid in a linear con-
centration dependent way, and in an aqueous PBS-based solution 
(Schoonen et al., 2017). This esterase catalytic activity was also 
observed with other esterase substrates such as p-nitrophenyl butyrate 
(p-NPB), polyethylene glycol MW 800-modifed p-NPA (p-NPA-PEG) and 
carboxyfuorescein diacetate (CFDA). In addition, an increase in His-tag- 
mediated esterase activity was observed upon assembling of an His- 
tagged cowpea chlorotic mottle virus (CCMV), showing that the bigger 
the protein-based structure, the higher the activity. The activity increase 
upon protein assembling could be associated with a cooperative effect 
between close-in-space imidazole rings of the His-tag from each protein 
building block. Besides, this plausible cooperative effect between adja-
cent imidazole rings was discarded, as very small activity changes were 
observed at alternative increasing number-of-histidines His-tags, 
namely H-His-NH2, H-His6-NH2 and H-His12-NH2. This was indicative 
of the irrespective influence of the number of close histidines into the 
final catalytic capacity of the tag. Finally, in a further step, the addition 
of a His-tag into an enzyme structure can generate additional functions 
(dual-active enzymes) as reported in a His-tagged phenylacetone mon-
ooxygenase (His6-PAMO) able to hydrolyze p-nitroacetophenone to p- 
NP (via p-NPA), apart from its intrinsic natural oxidoreductase activity 
(from phenylacetone to benzyl acetate). Interestingly, this gain of 
function was inhibited in presence of a molar excess of NiCl2, which was 
able to specifically bind to the imidazole ring and block its catalytic 
reactivity (Schoonen et al., 2017). 
Because of that, the catalytic propensity of his-tags must also be 
considered when designing novel protein-based materials, to address 
undesired scenarios of gain of function. 
9. Concluding remarks 
Although short histidine-rich peptides were initially developed as 
tags for recombinant protein purification, their pleiotropic nature has 
facilitated their progressive and expansive adaptation as functional and 
structural agents in multiple biotechnological and biomedical fields that 
are sustained by protein-based materials. They range from catalysis to 
drug development, but include dozens of different refined uses such as 
designing advanced smart micro- and nano-scale materials, tools for 
precision medicines or for fine diagnosis approaches. Such innovative 
applications open exciting possibilities to tailor proteins as powerful 
devices with unexpected regulatable properties, as purpose-tailored 
functional devices. 
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